![Charles W. Bishop](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles W. Bishop
Plus aucun poste en cours
Historique de carrière de Charles W. Bishop
Anciens postes connus de Charles W. Bishop
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cytochroma, Inc.
![]() Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Directeur/Membre du Conseil | 01/06/2006 | 01/03/2013 |
Directeur Général | 01/06/2006 | 01/03/2013 | |
President | 01/06/2006 | 01/03/2013 | |
Proventiv Therapeutics LLC
![]() Proventiv Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of OPKO Health, Inc., Proventiv Therapeutics LLC is a company that develops vitamin D therapeutics. The company is based in Fitchburg, WI. The company was founded by Keith Crawford, Eric J. Messner, Charles W. Bishop. Proventiv Therapeutics was acquired by Cytochroma, Inc. on June 29, 2006. | Fondateur | 01/09/2005 | 01/06/2006 |
President | 01/09/2005 | 01/06/2006 | |
Bone Care International, Inc.
![]() Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Directeur Technique/Scientifique/R&D | 01/09/1987 | 01/06/2005 |
Receptor Therapeutics, Inc.
![]() Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - | - |
PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - | - |
Formation de Charles W. Bishop
University of Virginia | Undergraduate Degree |
Virginia Polytechnic Institute & State University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Canada | 3 |
Opérationnelle
Director/Board Member | 2 |
President | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
Entreprise privées | 4 |
---|---|
Cytochroma, Inc.
![]() Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
Bone Care International, Inc.
![]() Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Health Technology |
Proventiv Therapeutics LLC
![]() Proventiv Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of OPKO Health, Inc., Proventiv Therapeutics LLC is a company that develops vitamin D therapeutics. The company is based in Fitchburg, WI. The company was founded by Keith Crawford, Eric J. Messner, Charles W. Bishop. Proventiv Therapeutics was acquired by Cytochroma, Inc. on June 29, 2006. | Health Technology |
Receptor Therapeutics, Inc.
![]() Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Health Technology |
- Bourse
- Insiders
- Charles W. Bishop
- Expérience